MARIOTTI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 407.376
NA - Nord America 25.758
AS - Asia 10.838
SA - Sud America 1.584
Continente sconosciuto - Info sul continente non disponibili 919
AF - Africa 252
OC - Oceania 31
Totale 446.758
Nazione #
IT - Italia 396.894
US - Stati Uniti d'America 25.280
CN - Cina 4.035
SG - Singapore 3.975
NL - Olanda 3.028
UA - Ucraina 2.088
BR - Brasile 1.208
SE - Svezia 1.207
FR - Francia 942
VN - Vietnam 860
GB - Regno Unito 792
FI - Finlandia 778
DE - Germania 775
HK - Hong Kong 412
IN - India 315
CA - Canada 250
KR - Corea 242
BD - Bangladesh 209
PL - Polonia 132
TR - Turchia 120
MX - Messico 115
AR - Argentina 111
IQ - Iraq 107
RU - Federazione Russa 99
EC - Ecuador 81
ES - Italia 78
BE - Belgio 72
ID - Indonesia 69
JP - Giappone 65
CH - Svizzera 62
RO - Romania 56
PK - Pakistan 53
ZA - Sudafrica 52
AL - Albania 51
CO - Colombia 46
SA - Arabia Saudita 45
MA - Marocco 42
SM - San Marino 39
JO - Giordania 38
PH - Filippine 38
IR - Iran 34
AT - Austria 32
CL - Cile 32
IE - Irlanda 31
VE - Venezuela 31
EG - Egitto 30
KE - Kenya 28
IL - Israele 26
PY - Paraguay 26
UZ - Uzbekistan 26
JM - Giamaica 25
NO - Norvegia 25
PT - Portogallo 24
GR - Grecia 23
MY - Malesia 23
AU - Australia 22
EU - Europa 22
TN - Tunisia 21
PE - Perù 20
CR - Costa Rica 19
LT - Lituania 19
MU - Mauritius 19
RS - Serbia 17
TH - Thailandia 17
UY - Uruguay 17
CZ - Repubblica Ceca 16
HU - Ungheria 16
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
AZ - Azerbaigian 13
KZ - Kazakistan 12
NP - Nepal 12
OM - Oman 12
BG - Bulgaria 11
PS - Palestinian Territory 10
BO - Bolivia 9
DK - Danimarca 9
GT - Guatemala 9
PA - Panama 9
TW - Taiwan 9
BA - Bosnia-Erzegovina 8
BY - Bielorussia 8
ET - Etiopia 8
HN - Honduras 8
KG - Kirghizistan 8
MD - Moldavia 8
NG - Nigeria 8
GE - Georgia 7
HR - Croazia 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
LB - Libano 6
NZ - Nuova Zelanda 6
BB - Barbados 5
MK - Macedonia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
AO - Angola 4
EE - Estonia 4
Totale 445.775
Città #
Cagliari 356.635
Uta 5.991
Rome 3.479
Milan 2.252
Fairfield 2.040
Singapore 1.948
Ashburn 1.936
Woodbridge 1.900
Amsterdam 1.893
Chandler 1.649
Houston 1.348
San Jose 1.326
Boardman 1.170
Dallas 1.146
Ann Arbor 1.064
Jacksonville 996
Wilmington 978
Naples 853
Nyköping 780
Seattle 755
Beijing 732
Cambridge 674
Bologna 614
Florence 588
Los Angeles 521
Helsinki 502
Dearborn 436
Bari 396
Catania 390
Hong Kong 379
Council Bluffs 378
Nanjing 374
Turin 373
Palermo 368
Hefei 343
Lauterbourg 324
Boston 308
Ho Chi Minh City 293
The Dalles 292
Buffalo 276
Santa Clara 276
New York 268
Seoul 234
Verona 224
Shanghai 218
Padova 203
Genoa 195
Hanoi 194
Toronto 136
Pescara 124
Shenyang 124
San Diego 120
Guangzhou 116
Hebei 113
Parma 113
Brescia 111
Venice 108
Atlanta 105
Pisa 104
Jiaxing 103
Mountain View 103
Nanchang 103
Modena 98
Reggio Emilia 97
Sassari 97
São Paulo 94
Messina 92
Redwood City 88
Livorno 84
Munich 83
Tianjin 81
Taranto 77
Hangzhou 76
Vicenza 76
Changsha 75
Orem 75
Perugia 75
Salerno 75
Chicago 74
Monza 74
London 73
Frankfurt am Main 72
Bergamo 71
Columbus 71
Napoli 66
Torino 65
Zhengzhou 61
Lucca 60
Phoenix 60
Brooklyn 58
Trieste 57
Orange 55
San Mateo 54
Rimini 53
Tokyo 50
Treviso 50
Jinan 49
Dong Ket 48
Brussels 47
Lecce 47
Totale 404.753
Nome #
Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA–PTH assay 34.703
Dosaggio della tireoglobulina nell’aspirato dei linfonodi del comparto centrale per l’identificazione intraoperatoria delle metastasi da carcinoma differenziato della tiroide. 14.873
Ricerca di galectina-3, HBME-1 e grading delle atipie nell’agoaspirato dei noduli tiroidei con citologia indeterminata: risultati preliminari. 11.025
L’iperplasia delle cellule “c” parafollicolari senza mutazione del protooncogene ret: descrizione e implicazioni diagnostiche di alcuni casi clinici. 5.003
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.889
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.796
Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view 4.061
Dosaggio della tireoglobulina (TG) negli agoaspirati linfonodali in pazienti con anticorpi anti-Tg (TgAb) circolanti. 3.902
Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe 3.899
Hurthle tumors: a class of thyroid malignancy with massive chromosome disturbance 3.848
Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study 3.824
Subclinical ocular alterations in thyroid eye disease. An additional score to predict the progression of disease 3.552
Subclinical alterations of extraocular muscles in Graves' Disease 3.528
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 3.433
Cortical adrenal mitochondrial morphology changes in functional state: new insights 3.309
Associazione tra carcinoma papillare della tiroide e tiroidite cronica autoimmune: nuove conferme da un ampio studio prospettico. 3.299
Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED 3.200
High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up 3.180
Assessing RET gene breakage in thyroid fine needle aspiration by fish: advantages and limits 3.111
Risultati di un ampio studio prospettico sull’associazione tra la tiroidite di Hashimoto e il carcinoma papillare della tiroide. 3.109
Association between autoimmune thyroiditis and papillary thyroid carcinoma: new confirmations from a large prospective study. 2.989
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.988
Median eminence dopaminergic terminals: a novel auto-immune target in neuro/endocrine disease 2.974
Score ecografico del rischio di malignità dei noduli tiroidei (TI-RADS): risultati citologici di uno studio prospettico di noduli con tiroidite di Hashimoto vs noduli senza tiroidite di Hashimoto. 2.971
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.957
Differentiated thyroid cancer: indications and extent of central neck dissection--our experience. 2.952
null 2.930
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.900
RET/PTC rearrangements in hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.831
Intertriginous and seborrheic dermatitis-like lesions in an endocrine patient 2.810
Predictive factors of malignancy in follicular thyroid nodules (THY3): Our experience on 324 patients 2.780
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.718
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.716
Primary thyroid leiomyosarcoma: a case report and review of the literature 2.677
Utilità della scintigrafia con 99MTC-SestaMIBI nella diagnosi e nella gestione della tireotossicosi indotta da amiodarone. 2.663
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies 2.663
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.644
Diagnosi differenziale del nodulo tiroideo: la calcemia non è mai utile? 2.582
Thyroid autoimmunity and thyroid cancer: pathological and molecular study in a longitudinal series of unselected nodules. 2.536
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report 2.504
Amiodarone-induced thyrotoxicosis. A review 2.494
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.482
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.461
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.457
Thyroid dysfunction in patients with metastatic carcinoma treated with Sunitinib: is thyroid autoimmunity involved? 2.411
Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis 2.397
High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients. 2.394
Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules 2.342
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.342
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.340
RET/PTC rearragements in Hashimoto’s thyroiditis nodules. 2.327
Autoimmunita’ tiroidea e carcinoma della tiroide: studio prospettico citologico, molecolare e istologico. 2.318
Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis 2.317
Fifteen-year follow-up of thyroid function in lithium patients 2.313
RET/PTC rearrangements in Hashimoto’s thyroiditis nodules 2.313
RET/PTC rearrangement in Hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.310
HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB 2.248
A genetic epidemiology study of congenital adrenal hyperplasia in Italy 2.243
Higher prevalence of thyroid cancer in patients with thyroid nodules (TN) and Hashimoto’s Thyroiditis (HT) at the first clinical evaluation compared to TN patients without thyroid autoimmunity and HT patients without TN followed-up for 1-9 years. 2.233
Riarrangiamenti RET/PTC in noduli insorti in tiroidite d’Hashimoto 2.226
RET/PTC rearrangements in unselected nodules from patients with Hashimoto’s thyroiditis 2.218
The birth and rise of a craniopharyngioma: the radiological evolution of an incidental craniopharyngioma detected on serial MRI during medical treatment of a macroprolactinoma 2.183
3-D structure of mitochondrial cristae in rat adrenal cortex varies after acute stimulation with ACTH and CRH 2.166
Area di intensa iodocaptazione al WBS con 131I simulante metastasi polmonare causata da angioma capillare a basso flusso. 2.141
The diagnostic value of parathyroid assay in wash-out fluid from fine needle aspiration biopsy of neck masses in primary hyperparathyroid patients with uncertain 99mTC-SESTAMIBI scintigraphy. 2.133
Ipotiroidismo e autoimmunità tiroidea in pazienti affetti da carcinoma renale metastatico trattati con sunitinib con un follow-up di 30 mesi. 2.129
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.127
Risultati preliminari di uno studio longitudinale in pazienti affetti da morbo di Basedow con alterazioni subcliniche dei muscoli oculari. 2.102
I noduli tiroidei e le tireopatie autoimmuni interferiscono con la scintigrafia sesta-MIBI e con l’ecografia nella localizzazione delle paratiroidi nell’iperparatiroidismo primitivo. 2.058
Prevalence of thyroid cancer in patients with hashimoto’s thyroiditis with or without nodules at the first clinical evaluation and in the subsequent follow-up. 2.052
Differenze nella prevalenza del carcinoma papillare della tiroide (PTC) nei pazienti con noduli tiroidei (NT) associati a tiroidite di Hashimoto (HT) alla prima diagnosi rispetto ai pazienti con NT senza TH e ai pazienti con TH esordita prima dei NT. 2.025
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 1.998
Intraoperative parathyroid hormone assay during focused parathyroidectomy for primary hyperparathyroidism: is it really mandatory? 1.976
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a single centre experience. 1.964
Hashimoto’s thyroiditis and thyroid cancer: a case-control study of unselected patients with thyroid nodules submitted to cytological and hystological examination. 1.961
Prevalence of overweight and obesity in Sardinian adolescents 1.949
High prevalence of autoimmune thyroid disease in thyroids with oncocytic tumors. 1.894
High prevalence of subclinical extraocular muscles alterations in graves’ disease patients asymptomatic for active graves’orbitopathy 1.812
Fibrinogen and D-dimer levels in autoimmune subclinical and overt hypothyroidism and effects of levothyroxine treatment. 1.792
99mTc-Sestaminbi scan is not useful in the pre-surgical evaluation of thyroid nodules with oncocytic cytology. 1.784
Asociation beween thyroid autoimmunità and papillary thyroid carcinoma: recent confirmation form a prospective study. 1.777
Brain perfusion abnormalities showed by 99mTc-ECD SPECT in patients with autoimmune thyroid disorders 1.776
HYPOTHALAMIC-Pituitary axis in aps i: novel autoantibody targets possibly related to endocrine disfunctions 1.751
Elevata prevalenza di alterazioni subcliniche dei muscoli extraoculari in pazienti con morbo di Basedow asintomatici per oftalmopatia attiva. 1.749
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.747
Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association? 1.742
Utilità dell’ecocolor Doppler nella diagnosi differenziale tra gozzo multinodulare tossico e variante multinodulare del morbo di Basedow. 1.730
null 1.717
99mTc-SESTAMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. 1.642
The usefulness of calcitonin assay in fine needle aspiration biopsy (FNAB) fluid of neck masses of patients with primitive and metastatic medullary thyroid carcinoma (MTC). 1.641
Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function 1.641
99mTc-Sesta-MIBI thyroid scan in the differential diagnosis of amiodarone-induced thyrotoxicosis. 1.613
Ricerca della mutazione BRAFV600E e del riarrangiamento RET/PTC negli agoaspirati tiroidei in pazienti sardi 1.612
Identificazione e uso di sonde molecolari per una migliore caratterizzazione pre-chirurgica dei noduli tiroidei 1.610
99mTc-SestaMIBI scintigraphy of thyroid gland in patient with primary hyperparathyroidism: unusual features due to coesistence of a thyroid papillary carcinoma 1.599
Galectina-3 e HBME-1 nell’agoaspirato dei noduli a citologia indeterminata: confronto con I parametri eco-color-doppler. 1.584
Classification and Etiopathogenesis of Hypothyroidism 1.583
Identificazione e uso di sonde molecolari per una migliore caratterizzazione pre-chirurgica del noduli tiroidei. 1.536
Coexistent thyroid pathology may impair parathyroid localization in primary hyperparathyroidism: usefulness of PTH assay in FNAB fluid wash-out. 1.529
Functional characterization of aCDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 1.520
Totale 300.860
Categoria #
all - tutte 590.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 590.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217.258 0 1.740 1.176 1.523 1.735 1.501 1.284 1.005 1.499 1.617 2.159 2.019
2022/202329.516 2.309 3.062 2.893 2.252 2.329 2.553 1.637 3.186 2.457 2.086 2.856 1.896
2023/202438.480 2.403 1.706 1.867 2.709 3.353 4.983 5.325 3.254 2.226 3.004 3.828 3.822
2024/202582.925 25.696 15.667 18.561 5.774 3.266 3.486 4.543 1.051 1.459 1.105 1.179 1.138
2025/202624.820 1.595 961 2.751 1.817 1.452 1.851 3.104 2.099 3.798 2.892 1.638 862
2026/20271.642 628 1.014 0 0 0 0 0 0 0 0 0 0
Totale 446.758